Chemicals - Specialty
Compare Stocks
5 / 10Stock Comparison
CBT vs MPC vs VLO vs KRO vs TROX
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Refining & Marketing
Oil & Gas Refining & Marketing
Chemicals - Specialty
Chemicals
CBT vs MPC vs VLO vs KRO vs TROX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Chemicals - Specialty | Oil & Gas Refining & Marketing | Oil & Gas Refining & Marketing | Chemicals - Specialty | Chemicals |
| Market Cap | $4.24B | $70.73B | $70.66B | $811M | $1.34B |
| Revenue (TTM) | $3.58B | $135.75B | $126.17B | $1.88B | $2.92B |
| Net Income (TTM) | $285M | $4.63B | $4.21B | $-134M | $-359M |
| Gross Margin | 24.8% | 8.8% | 7.2% | 10.1% | 5.8% |
| Operating Margin | 15.7% | 5.0% | 4.6% | -3.1% | -4.8% |
| Forward P/E | 13.0x | 10.9x | 10.0x | — | — |
| Total Debt | $1.22B | $34.36B | $11.70B | $577M | $3.59B |
| Cash & Equiv. | $258M | $3.67B | $4.69B | $37M | $211M |
CBT vs MPC vs VLO vs KRO vs TROX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cabot Corporation (CBT) | 100 | 227.5 | +127.5% |
| Marathon Petroleum … (MPC) | 100 | 689.4 | +589.4% |
| Valero Energy Corpo… (VLO) | 100 | 354.6 | +254.6% |
| Kronos Worldwide, I… (KRO) | 100 | 72.2 | -27.8% |
| Tronox Holdings plc (TROX) | 100 | 126.7 | +26.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CBT vs MPC vs VLO vs KRO vs TROX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CBT is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- 8.0% margin vs TROX's -12.3%
- 7.4% ROA vs KRO's -9.4%, ROIC 17.4% vs -1.9%
MPC is the clearest fit if your priority is long-term compounding.
- 6.6% 10Y total return vs VLO's 397.5%
VLO carries the broadest edge in this set and is the clearest fit for income & stability and sleep-well-at-night.
- Dividend streak 15 yrs, beta 0.27, yield 1.9%
- Lower volatility, beta 0.27, Low D/E 44.0%, current ratio 1.65x
- Better valuation composite
- Beta 0.27 vs TROX's 2.37, lower leverage
KRO ranks third and is worth considering specifically for growth exposure and defensive.
- Rev growth -1.5%, EPS growth -228.0%, 3Y rev CAGR -1.2%
- Beta 1.57, yield 2.8%, current ratio 2.70x
- -1.5% revenue growth vs CBT's -7.0%
TROX is the clearest fit if your priority is dividends.
- 3.6% yield, vs VLO's 1.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -1.5% revenue growth vs CBT's -7.0% | |
| Value | Better valuation composite | |
| Quality / Margins | 8.0% margin vs TROX's -12.3% | |
| Stability / Safety | Beta 0.27 vs TROX's 2.37, lower leverage | |
| Dividends | 3.6% yield, vs VLO's 1.9% | |
| Momentum (1Y) | +106.0% vs KRO's -1.2% | |
| Efficiency (ROA) | 7.4% ROA vs KRO's -9.4%, ROIC 17.4% vs -1.9% |
CBT vs MPC vs VLO vs KRO vs TROX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CBT vs MPC vs VLO vs KRO vs TROX — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CBT leads in 2 of 6 categories
MPC leads 1 • VLO leads 0 • KRO leads 0 • TROX leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CBT leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MPC is the larger business by revenue, generating $135.8B annually — 72.2x KRO's $1.9B. CBT is the more profitable business, keeping 8.0% of every revenue dollar as net income compared to TROX's -12.3%. On growth, MPC holds the edge at +9.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $3.6B | $135.8B | $126.2B | $1.9B | $2.9B |
| EBITDAEarnings before interest/tax | $731M | $10.1B | $9.0B | -$9M | $166M |
| Net IncomeAfter-tax profit | $285M | $4.6B | $4.2B | -$134M | -$359M |
| Free Cash FlowCash after capex | $459M | $5.7B | $5.9B | $35M | -$139M |
| Gross MarginGross profit ÷ Revenue | +24.8% | +8.8% | +7.2% | +10.1% | +5.8% |
| Operating MarginEBIT ÷ Revenue | +15.7% | +5.0% | +4.6% | -3.1% | -4.8% |
| Net MarginNet income ÷ Revenue | +8.0% | +3.4% | +3.3% | -7.1% | -12.3% |
| FCF MarginFCF ÷ Revenue | +12.8% | +4.2% | +4.7% | +1.9% | -4.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -3.4% | +9.7% | +7.0% | +4.1% | +3.0% |
| EPS Growth (YoY)Latest quarter vs prior year | -23.1% | +8.2% | +3.2% | -126.1% | +7.1% |
Valuation Metrics
Evenly matched — CBT and KRO each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 13.5x trailing earnings, CBT trades at a 57% valuation discount to VLO's 31.2x P/E. On an enterprise value basis, CBT's 6.7x EV/EBITDA is more attractive than KRO's 40.7x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $4.2B | $70.7B | $70.7B | $811M | $1.3B |
| Enterprise ValueMkt cap + debt − cash | $5.2B | $101.4B | $77.7B | $1.4B | $4.7B |
| Trailing P/EPrice ÷ TTM EPS | 13.50x | 18.26x | 31.22x | -7.34x | -2.83x |
| Forward P/EPrice ÷ next-FY EPS est. | 13.04x | 10.91x | 10.02x | — | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | 6.71x | 11.24x | 10.40x | 40.71x | 16.80x |
| Price / SalesMarket cap ÷ Revenue | 1.14x | 0.53x | 0.58x | 0.44x | 0.46x |
| Price / BookPrice ÷ Book value/share | 2.58x | 3.07x | 2.74x | 1.08x | 0.92x |
| Price / FCFMarket cap ÷ FCF | 10.86x | 14.84x | 14.05x | — | — |
Profitability & Efficiency
CBT leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
MPC delivers a 19.6% return on equity — every $100 of shareholder capital generates $20 in annual profit, vs $-30 for TROX. VLO carries lower financial leverage with a 0.44x debt-to-equity ratio, signaling a more conservative balance sheet compared to TROX's 2.48x. On the Piotroski fundamental quality scale (0–9), MPC scores 7/9 vs TROX's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +16.8% | +19.6% | +15.7% | -17.0% | -30.4% |
| ROA (TTM)Return on assets | +7.4% | +5.5% | +7.1% | -9.4% | -7.7% |
| ROICReturn on invested capital | +17.4% | +8.3% | +9.5% | -1.9% | -0.3% |
| ROCEReturn on capital employed | +21.3% | +9.3% | +9.7% | -2.2% | -0.4% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 6 | 5 | 2 |
| Debt / EquityFinancial leverage | 0.71x | 1.43x | 0.44x | 0.77x | 2.48x |
| Net DebtTotal debt minus cash | $957M | $30.7B | $7.0B | $540M | $3.4B |
| Cash & Equiv.Liquid assets | $258M | $3.7B | $4.7B | $37M | $211M |
| Total DebtShort + long-term debt | $1.2B | $34.4B | $11.7B | $577M | $3.6B |
| Interest CoverageEBIT ÷ Interest expense | 14.72x | 6.36x | 10.63x | -2.32x | -1.16x |
Total Returns (Dividends Reinvested)
MPC leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MPC five years ago would be worth $42,948 today (with dividends reinvested), compared to $4,493 for TROX. Over the past 12 months, VLO leads with a +106.0% total return vs KRO's -1.2%. The 3-year compound annual growth rate (CAGR) favors MPC at 32.5% vs TROX's -8.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +21.9% | +47.3% | +43.7% | +58.5% | +98.1% |
| 1-Year ReturnPast 12 months | +13.8% | +70.1% | +106.0% | -1.2% | +76.9% |
| 3-Year ReturnCumulative with dividends | +22.5% | +132.5% | +132.2% | -0.7% | -23.6% |
| 5-Year ReturnCumulative with dividends | +43.2% | +329.5% | +219.6% | -43.9% | -55.1% |
| 10-Year ReturnCumulative with dividends | +115.7% | +664.3% | +397.5% | +129.0% | +116.1% |
| CAGR (3Y)Annualised 3-year return | +7.0% | +32.5% | +32.4% | -0.2% | -8.6% |
Risk & Volatility
Evenly matched — CBT and VLO each lead in 1 of 2 comparable metrics.
Risk & Volatility
VLO is the less volatile stock with a 0.27 beta — it tends to amplify market swings less than TROX's 2.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CBT currently trades 96.1% from its 52-week high vs TROX's 79.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.78x | 0.30x | 0.27x | 1.57x | 2.37x |
| 52-Week HighHighest price in past year | $84.60 | $261.61 | $258.43 | $7.90 | $10.59 |
| 52-Week LowLowest price in past year | $58.33 | $142.73 | $115.65 | $4.08 | $2.86 |
| % of 52W HighCurrent price vs 52-week peak | +96.1% | +92.6% | +91.4% | +89.2% | +79.4% |
| RSI (14)Momentum oscillator 0–100 | 71.7 | 58.0 | 47.8 | 63.4 | 58.5 |
| Avg Volume (50D)Average daily shares traded | 374K | 2.5M | 3.8M | 350K | 3.1M |
Analyst Outlook
Evenly matched — VLO and TROX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CBT as "Buy", MPC as "Buy", VLO as "Buy", KRO as "Hold", TROX as "Buy". Consensus price targets imply -4.0% upside for CBT (target: $78) vs -29.1% for KRO (target: $5). For income investors, TROX offers the higher dividend yield at 3.60% vs MPC's 1.54%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $78.00 | $214.78 | $214.67 | $5.00 | $7.25 |
| # AnalystsCovering analysts | 15 | 33 | 37 | 7 | 17 |
| Dividend YieldAnnual dividend ÷ price | +2.2% | +1.5% | +1.9% | +2.8% | +3.6% |
| Dividend StreakConsecutive years of raises | 4 | 4 | 15 | 0 | 0 |
| Dividend / ShareAnnual DPS | $1.77 | $3.74 | $4.55 | $0.20 | $0.30 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.0% | +4.9% | +3.7% | 0.0% | 0.0% |
CBT leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MPC leads in 1 (Total Returns). 3 tied.
CBT vs MPC vs VLO vs KRO vs TROX: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CBT or MPC or VLO or KRO or TROX a better buy right now?
For growth investors, Kronos Worldwide, Inc.
(KRO) is the stronger pick with -1. 5% revenue growth year-over-year, versus -7. 0% for Cabot Corporation (CBT). Cabot Corporation (CBT) offers the better valuation at 13. 5x trailing P/E (13. 0x forward), making it the more compelling value choice. Analysts rate Cabot Corporation (CBT) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CBT or MPC or VLO or KRO or TROX?
On trailing P/E, Cabot Corporation (CBT) is the cheapest at 13.
5x versus Valero Energy Corporation at 31. 2x. On forward P/E, Valero Energy Corporation is actually cheaper at 10. 0x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — CBT or MPC or VLO or KRO or TROX?
Over the past 5 years, Marathon Petroleum Corporation (MPC) delivered a total return of +329.
5%, compared to -55. 1% for Tronox Holdings plc (TROX). Over 10 years, the gap is even starker: MPC returned +664. 3% versus CBT's +115. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CBT or MPC or VLO or KRO or TROX?
By beta (market sensitivity over 5 years), Valero Energy Corporation (VLO) is the lower-risk stock at 0.
27β versus Tronox Holdings plc's 2. 37β — meaning TROX is approximately 782% more volatile than VLO relative to the S&P 500. On balance sheet safety, Valero Energy Corporation (VLO) carries a lower debt/equity ratio of 44% versus 2% for Tronox Holdings plc — giving it more financial flexibility in a downturn.
05Which is growing faster — CBT or MPC or VLO or KRO or TROX?
By revenue growth (latest reported year), Kronos Worldwide, Inc.
(KRO) is pulling ahead at -1. 5% versus -7. 0% for Cabot Corporation (CBT). On earnings-per-share growth, the picture is similar: Marathon Petroleum Corporation grew EPS 31. 5% year-over-year, compared to -890. 0% for Tronox Holdings plc. Over a 3-year CAGR, KRO leads at -1. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CBT or MPC or VLO or KRO or TROX?
Cabot Corporation (CBT) is the more profitable company, earning 8.
9% net margin versus -16. 2% for Tronox Holdings plc — meaning it keeps 8. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CBT leads at 16. 7% versus -1. 7% for KRO. At the gross margin level — before operating expenses — CBT leads at 25. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CBT or MPC or VLO or KRO or TROX more undervalued right now?
On forward earnings alone, Valero Energy Corporation (VLO) trades at 10.
0x forward P/E versus 13. 0x for Cabot Corporation — 3. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CBT: -4. 0% to $78. 00.
08Which pays a better dividend — CBT or MPC or VLO or KRO or TROX?
All stocks in this comparison pay dividends.
Tronox Holdings plc (TROX) offers the highest yield at 3. 6%, versus 1. 5% for Marathon Petroleum Corporation (MPC).
09Is CBT or MPC or VLO or KRO or TROX better for a retirement portfolio?
For long-horizon retirement investors, Marathon Petroleum Corporation (MPC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
30), 1. 5% yield, +664. 3% 10Y return). Tronox Holdings plc (TROX) carries a higher beta of 2. 37 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MPC: +664. 3%, TROX: +116. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CBT and MPC and VLO and KRO and TROX?
These companies operate in different sectors (CBT (Basic Materials) and MPC (Energy) and VLO (Energy) and KRO (Unknown) and TROX (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CBT is a small-cap deep-value stock; MPC is a mid-cap quality compounder stock; VLO is a mid-cap quality compounder stock; KRO is a small-cap quality compounder stock; TROX is a small-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.